Jan Bruha
Overview
Explore the profile of Jan Bruha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sojka L, Opattova A, Bartu L, Horak J, Korenkova V, Novosadova V, et al.
Oncol Lett
. 2023 Jan;
25(2):72.
PMID: 36688110
MUC13, a transmembrane mucin glycoprotein, is overexpressed in colorectal cancer (CRC), however, its regulation and functions are not fully understood. It has been shown that MUC13 protects colonic epithelial cells...
2.
Mukhtar M, Ashfield N, Vodickova L, Vymetalkova V, Levy M, Liska V, et al.
Nutrients
. 2022 Jul;
14(13).
PMID: 35807897
Background: Selenium manifests its biological effects through its incorporation into selenoproteins, which play several roles in countering oxidative and inflammatory responses implicated in colorectal carcinogenesis. Selenoprotein genetic variants may contribute...
3.
Kolencik D, Narayan S, Thiele J, McKinley D, Gerdtsson A, Welter L, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158910
The liquid biopsy has the potential to improve current clinical practice in oncology by providing real-time personalized information about a patient's disease status and response to treatment. In this study,...
4.
Vistejnova L, Liska V, Kumar A, Kreckova J, Vycital O, Bruha J, et al.
Int J Mol Sci
. 2021 Apr;
22(9).
PMID: 33919123
In liver surgery, biliary obstruction can lead to secondary biliary cirrhosis, a life-threatening disease with liver transplantation as the only curative treatment option. Mesenchymal stromal cells (MSC) have been shown...
5.
Navvabi N, Kolikova P, Hosek P, Zitricky F, Navvabi A, Vycital O, et al.
Cancer Genomics Proteomics
. 2021 Apr;
18(3):295-306.
PMID: 33893082
Background/aim: Colorectal cancer is currently the third leading cause of cancer-related deaths and recently, alternative splicing has risen as its important regulator and potential treatment target. In the present study,...
6.
Treska V, Bruha J, Liska V, Fichtl J, Prochazkova K, Petrakova T, et al.
In Vivo
. 2020 Sep;
34(5):2919-2925.
PMID: 32871833
Background/aim: Portal vein embolization (PVE) with autologous stem cells application (aHSC) is a method for future liver remnant volume (FLRV) increase. The aim of the study was to evaluate the...
7.
Fiala O, Sorejs O, Hosek P, Liska V, Vycital O, Bruha J, et al.
Cancer Genomics Proteomics
. 2020 Aug;
17(5):605-613.
PMID: 32859639
Background/aim: MicroRNAs (miRs) play an important role in the regulation of cancer-related processes and are promising candidates for cancer biomarkers. The aim of the study was to evaluate the association...
8.
cervenkova L, Vycital O, Bruha J, Rosendorf J, Palek R, Liska V, et al.
Sci Rep
. 2019 Dec;
9(1):19782.
PMID: 31874997
ATP-binding cassette (ABC) and solute carrier (SLC) transporters translocate diverse substances across cellular membranes and their deregulation may cause drug resistance of cancers. This study investigated significance of protein expression...
9.
Thiele J, Hosek P, Kralovcova E, Ostasov P, Liska V, Bruha J, et al.
Int J Mol Sci
. 2018 Sep;
19(9).
PMID: 30205577
Although colorectal cancer (CRC) is the third most frequent cause of cancer related death in Europe, clinically relevant biomarkers for therapy guidance and prognosis are insufficiently reliable. Long non-coding RNAs...
10.
Treska V, Fichtl J, Ludvik J, Bruha J, Liska V, Treskova I, et al.
Anticancer Res
. 2018 Sep;
38(9):5531-5537.
PMID: 30194213
Background: Portal vein embolization (PVE) and PVE with autologous mesenchymal stem cell application (PVE-MSC) increases future liver remnant volume (FLRV). The aim of this study was to compare both methods...